Catabasis Pharma (CATB) – Hot Corp. News
-
Catabasis Pharma (CATB) Phase 3 PolarisDMD Trial of Edasalonexent in Duchenne Muscular Dystrophy Did Not Meet Primary Endpoint
-
Catabasis Pharma (CATB) to Reduce Workforce by 42% as Part of Restructuring
-
-
-
Back to CATB Stock Lookup